Data Center

Showing 2072 articles
Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...

Business

Warsh Nomination Sparks Dollar Surge, Sends Precious Metals Tumbling

The U.S. dollar staged a sharp rally Friday, while gold and silver prices plunged, following President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank. The move, interpreted as a hawkish signal for monetary policy, combined with strong economic data to reshape market expectations.